Improving the lives of our patients.
We work tirelessly to create life changing treatments that help our patients live better and fuller lives.Learn More
Research & Development
We invest in innovative research and development through our own development or partnerships to best address the unmet needs of patientsLearn More
Acquiring Agios Pharmaceuticals’ Oncology business accelerates the execution of our Group strategy and deepens our portfolio and product offerings in the Oncology space.Learn More
Our CEO, David K. Lee, recently spoke with Luke Timmerman on his podcast, The Long Run, discussing how his upbringing influenced his desire to impact patient's lives directly, and how Servier is a different kind of pharmaceutical company.Learn More
Servier to Acquire Agios Pharmaceuticals' Oncology BusinessLearn More
Adobe Stock©Mat Hayward | Adobe Stock©REDPIXEL | Adobe Stock©Gorodenkoff | Adobe Stock©Monkey Business